CINXE.COM

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)

<!DOCTYPE html> <html lang="en"> <head><meta charset="utf-8" /><title> Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) </title><link href="../../../Content/Site.css" rel="stylesheet" /><link href="../../../Content/bootstrap-3.3.2-dist/css/bootstrap.min.css" rel="stylesheet" /><link href="../../../Content/bootstrap-3.3.2-dist/css/bootstrap.icon-large.min.css" rel="stylesheet" /><link href="//maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css" rel="stylesheet" /><link href="../../../Content/Custom.css" rel="stylesheet" /><link href="../../../favicon.ico" rel="shortcut icon" type="image/x-icon" /> <script src="/Scripts/modernizr-2.5.3.js"></script> <meta name="viewport" content="width=device-width" /> <script type="text/javascript" src="https://www.jcnnewswire.com/jquery/jquery-latest.min.js"> </script> <script type="text/javascript" src="https://www.jcnnewswire.com/jquery/jquery.fancybox.pack.js?v=2.1.5"></script> <link rel="stylesheet" type="text/css" href="https://www.jcnnewswire.com/jquery/jquery.fancybox.css?v=2.1.5" media="screen"> <style> .lang li { display:inline; } .lang a { color:#fff; } </style> <script type="text/javascript"> (function(c,l,a,r,i,t,y){ c[a]=c[a]||function(){(c[a].q=c[a].q||[]).push(arguments)}; t=l.createElement(r);t.async=1;t.src="https://www.clarity.ms/tag/"+i; y=l.getElementsByTagName(r)[0];y.parentNode.insertBefore(t,y); })(window, document, "clarity", "script", "559ucihkaw"); </script> </head> <body> <form method="post" action="./Nationwide-TV-Commercial-Launched-in-Japan-to-Raise-Awareness-About-MCI-(Mild-Cognitive-Impairment)" onsubmit="javascript:return WebForm_OnSubmit();" id="ctl01"> <div class="aspNetHidden"> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKLTU1NzE2ODMwMmRkUsbWT9g+umtmEgNprCuzC2jmsYeBXr0ebxqmSnQcvxQ=" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['ctl01']; if (!theForm) { theForm = document.ctl01; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=YcG_1mlPARhRW7O4sA9bWHA-qI2d_t_BO06OeFBhoaiREhheyXs3-1psdTUSDOHCoQeBPKlq2r8vu_cSQNfig-Is-AxTXJhRKwfH8V2oM9c1&amp;t=638628512640000000" type="text/javascript"></script> <script src="/WebResource.axd?d=bIpPyEdzAMer_bwfyhWa6rFaO8WGfxnN2PvV0BTsVTDvSo40Rw6pGSZlPV1TZTu152c0lKoeiKGVeRIzWI8ylmApYjdRpTU999mo98-2hDs1&amp;t=638628512640000000" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ function WebForm_OnSubmit() { if (typeof(ValidatorOnSubmit) == "function" && ValidatorOnSubmit() == false) return false; return true; } //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAOAmRkYVItsmcdM2BVTyCBusK8Qcg6x7YEKBpnNUn26Cy8zACrOsmKsedR3ZCAsXqN0re5U5WkOThO8VFjyJV4Rm2Dm3cZiptc0ihyu5qN1NA==" /> </div> <header> <div style="background-color:#000;"> <div class="content-wrapper"> <div style="color:#fff;padding-bottom:22px;"> <span style="float:right;"> <ul class="lang"> <li style="font-size:12px;color:#ABA9A9;"> <a href="/english/"> ENGLISH</a> </li> <li style="font-size:12px;color:#ABA9A9;">|</li> <li style="font-size:12px;color:#ABA9A9;"><a href="/japanese/"> JAPANESE</a></li> <li style="font-size:12px;color:#ABA9A9;">&nbsp;|&nbsp;</li> <li style="font-size:12px;color:#fff;"> CONNECT WITH US:</li> <li class="nolink"> <a href="https://www.facebook.com/jcnnewswire" target="_blank" class="social"> <i class="fa fa-facebook-square"></i></a> </li> <li class="nolink"> <a href="https://twitter.com/JCNNewswire" target="_blank" class="social"><i class="fa fa-twitter-square"></i></a> </li> <li class="nolink"> <a href="/rssfeed/" class="social"><i class="fa fa-rss-square"></i></a> </li> </ul> </span> </div> </div> </div> <br /> <div class="content-wrapper"> <div class="feature-float-left"> <p class="site-title"><a href="../../../"> <img src="/Images/JCN-Newswire.jpg" width="300px"/></a></p> </div> <div class="float-right"> <nav class="topnav"> <ul class="nav nav-tabs"> <li role="presentation"><a href="../../../">Home</a></li> <li role="presentation"><a href="../../../About/">About</a></li> <li role="presentation"><a href="../../../Contact/">Contact</a></li> <li role="presentation"><a href="../../../Client/" id="A1">Log in</a></li> <li style="padding-top:5px;"> <span id="RequiredFieldSearch" style="color:Red;visibility:hidden;">*</span> <input name="ctl00$searchstring" type="text" id="searchstring" placeholder="Search for..." style="width:150px;height:30px;font-size:14px;" /><input type="submit" name="ctl00$SearchButton" value="Go!" onclick="javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions(&quot;ctl00$SearchButton&quot;, &quot;&quot;, true, &quot;&quot;, &quot;&quot;, false, false))" id="SearchButton" class="btn btn-default" type="submit" style="height:30px;font-size: 13px;margin-left:2px;background-color:#f2f2f2;border-color:#ccc;" /> </li> </ul> </nav> </div> </div> </header> <div id="body"> <section class="content-wrapper main-content clear-fix"> <!-- Go to www.addthis.com/dashboard to customize your tools --> <script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-54f7fe387839d451" async="async"></script> <ol class="breadcrumb"> <li><a href="/">Home</a></li> <li class="active">Press release</li> </ol> <table> <!-- Body --> <tr valign="top"><td> <div class="col-lg-12 clearfix"> <table width="100%"> <tr> <td> <div id="MainContent_CompanyInfo"> <span id="MainContent_releaseDate" class="small">Nov 15, 2024 17:33 JST</span><br /> <span id="MainContent_companyLogo"><img src="http://www.jcnnewswire.com/image/company/eisai.240.jpg" class="companyLogo"></span><br /> <span id="MainContent_companySource" class="small">Source: <a href="http://www.eisai.com" target="_blank">Eisai</a></span> </div> </td> <td class="float-right"> <div class="addthis_sharing_toolbox"></div> </td> </tr> </table> </div> <p style="padding-bottom:100px;"></p> <div class="col-lg-9"> <table> <tr><td> <div align="justify" class="title"><span id="MainContent_HeadLine" class="header">Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)</span></div> <div align="justify"><strong></strong></div> <div align="justify"><span id="MainContent_Body" class="bodytext"><p><strong>TOKYO, Nov 15, 2024 - (JCN Newswire) - </strong>Eisai Co., Ltd. and Biogen Japan Ltd announced today that a TV commercial will be broadcast nationwide in Japan from November 15 with the aim of increasing public understanding of MCI (Mild Cognitive Impairment).<br><br><img style="display: block; margin-left: auto; margin-right: auto;" src="https://photos.acnnewswire.com/EisaiBiogen.jpg" alt="" width="650" height="366"></p> <p>MCI refers to the stage between "normal brain function" and "dementia," where the individual can still lead an independent daily life but cognitive functions of the brain, such as memory and judgment, have somewhat declined. If cognitive function further declines from the MCI stage to a state where it disrupts daily life and care becomes necessary, it is then diagnosed as dementia.</p> <p>In 2022, there were 5.58 million people living with MCI in Japan, accounting for 15.5% of those aged 65 and over, and estimated to reach 6.12 million by 2040. 1 While MCI is often referred to as a precursor to dementia, it doesn&rsquo;t necessarily progress to dementia. Depending on the cause, the condition may be maintained, or even improved. If you are concerned about forgetfulness, early consultation with a specialist is important for the early detection of MCI and clarification of its cause, through which appropriate measures can be taken to prevent the progression from MCI to dementia. &nbsp;</p> <p>This TV commercial tells the story of a mother whose daughter worries for her, always telling her "You just said that earlier". The mother realizes that the forgetfulness she attributed to old age might in fact be due to MCI, leading her to seek medical advice.</p> <p>A survey2&nbsp;conducted by Eisai showed that awareness of the term "MCI" was 12%, while understanding of it was only 2%, which is still low. Through this TV commercial, Eisai and Biogen Japan hope to increase awareness of MCI among a broader range of people, thereby raising public interest in cognitive impairment and contributing to the early detection and treatment of MCI.</p> <p>(1) Research on the Prevalence and Future Projections of Dementia and Mild Cognitive Impairment, 2023 Elderly Health&nbsp; Promotion Project Grant, Professor Toshiharu Ninomiya, Kyushu University<br>(2) Internet survey<br>Target: Japan nationwide, men and women aged 60-70, 2000 responses<br>Survey period: February 2024<br>Survey conducted by: Macromill Carenet, Inc.&nbsp; &nbsp;</p> <p><strong>About the TV Commercial</strong></p> <p>Title: MCI Disease Awareness TV Commercial "Don't Miss it, MCI" Edition (15 seconds/30 seconds)<br>TV Broadcast Start: November 15, 2024<br>Broadcasting Area: Japan nationwide<br>Main CM Video: Published on YouTube from November 15<br>(<a href="https://youtube.com/@patients_eisai?si=vLaA-y07QAlORHLa">https://youtube.com/@patients_eisai?si=vLaA-y07QAlORHLa</a>)</p> <p><strong>About&nbsp;Eisai</strong></p> <p>Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as&nbsp;human health care&nbsp;(hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&amp;D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology, Oncology and Global Health.</p> <p>Theoria technologies Co., Ltd., a member of the Eisai Group, operates the dementia portal site "Theotol" (<a href="https://theotol.soudan-e65.com/">https://theotol.soudan-e65.com/</a>), which provides easy-to-understand contents and services for the general public about MCI and various types of dementia, their causes, treatments, as well as caregiving methods and personal experiences. (Japanese only)</p> <p><strong>About&nbsp;Biogen Japan</strong></p> <p>Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients&rsquo; lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.</p> <p>We routinely post information on Biogen Japan that may be important to investors on our website at https://www.biogen.com/ and social media&nbsp;<a href="https://www.twitter.com/biogen">X</a>,&nbsp;<a href="https://www.linkedin.com/company/biogen-">LinkedIn</a>,<a href="https://www.facebook.com/Biogen/">&nbsp;Facebook</a>,&nbsp;<a href="https://www.youtube.com/c/biogen">YouTube</a></p> <p>MEDIA CONTACTS<br>Eisai Co., Ltd.<br>Public Relations Department<br>TEL&#65306;+81 (0)3-3817-5120</p> <p>Biogen Japan, Ltd.<br>Corporate Affairs<br>TEL&#65306;&#65291;81-70-1501-4315<br>E-mail: <a href="mailto:Japan-PA@biogen.com">Japan-PA@biogen.com</a></p></span></div> <div align="justify"><span id="MainContent_CompanyName" class="bodytext"></span></div> <div align="justify"><span id="MainContent_CompanyBoiler" class="bodytext"></span></div> <div align="justify"><span id="MainContent_Contact" class="bodytext"></span></div> <div align="justify"><span id="MainContent_Source" class="note">Source: Eisai<BR />Sectors: Healthcare & Pharm <BR /><BR /></span></div> <div align="justify"><span id="MainContent_Copyright" class="bodytext"><p>Copyright 漏2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.<p></span></div> </td></tr> </table> <hr /> <h3><span id="MainContent_Label1">Latest Release</span></h3> <span id="MainContent_LatestRelease_LatestPressRelease"><table width="100%" cellpadding=0 cellspacing=0><tr><td class="articleDate"><img title="Toyota Motor Corporation" src="http://www.jcnnewswire.com/image/toppage/ToyotaBb.68.jpg"><br /><a href="/pressrelease/96133/3/TOYOTA-GAZOO-Racing-starts-WEC-season-with-Qatar-challenge" class="newslink">TOYOTA GAZOO Racing starts WEC season with Qatar challenge</a><br /><span class="note"> Feb 17, 2025 18:45 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Honda Motor Co, Ltd" src="http://www.jcnnewswire.com/image/toppage/honda.gif"><br /><a href="/pressrelease/96131/3/FLAT-OUT-IN-TOKYO-Red-Bull-Showrun-x-Powered-by-Honda-April-2-(Wed)" class="newslink">FLAT OUT IN TOKYO "Red Bull Showrun x Powered by Honda" April 2 (Wed)</a><br /><span class="note"> Feb 17, 2025 16:21 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Toyota Motor Corporation" src="http://www.jcnnewswire.com/image/toppage/ToyotaBb.68.jpg"><br /><a href="/pressrelease/96129/3/Thrilling-TOYOTA-GAZOO-Racing-one-two-on-Swedish-snow" class="newslink">Thrilling TOYOTA GAZOO Racing one-two on Swedish snow</a><br /><span class="note"> Feb 17, 2025 14:23 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Mitsubishi Corporation" src="http://www.jcnnewswire.com/image/toppage/MC.68.jpg"><br /><a href="/pressrelease/96127/3/Launch-of-Joint-Demonstration-Experiment-of-Remote-Provision-of-GPU-Computing-Power" class="newslink">Launch of Joint Demonstration Experiment of Remote Provision of GPU Computing Power</a><br /><span class="note"> Feb 17, 2025 14:10 JST</span><br /></td></tr><tr><td class="articleDate"><img title="mazda" src="http://www.jcnnewswire.com/image/toppage/MazdaLogo.48.jpg"><br /><a href="/pressrelease/96066/3/Mazda-to-Strengthen-Production-and-Sales-Systems-in-Thailand" class="newslink">Mazda to Strengthen Production and Sales Systems in Thailand</a><br /><span class="note"> Feb 14, 2025 17:04 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Toyota Motor Corporation" src="http://www.jcnnewswire.com/image/toppage/ToyotaBb.68.jpg"><br /><a href="/pressrelease/96060/3/Toyota-Develops-New-Fuel-Cell-System" class="newslink">Toyota Develops New Fuel Cell System</a><br /><span class="note"> Feb 14, 2025 15:27 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Eisai" src="http://www.jcnnewswire.com/image/toppage/eisai45.jpg"><br /><a href="/pressrelease/96056/3/Development-of-Prediction-Model-for-Brain-Amyloid-Beta-Accumulation-for-Early-Screening-of-Alzheimer" class="newslink">Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease</a><br /><span class="note"> Feb 14, 2025 12:09 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Mitsubishi Motors" src="http://www.jcnnewswire.com/image/toppage/MMT1902.jpg"><br /><a href="/pressrelease/96017/3/Nissan,-Honda-and-Mitsubishi-Motors-terminate-MOU-regarding-consideration-of-tripartite-collaboratio" class="newslink">Nissan, Honda and Mitsubishi Motors terminate MOU regarding consideration of tripartite collaboration</a><br /><span class="note"> Feb 13, 2025 16:20 JST</span><br /></td></tr><tr><td class="articleDate"><img title="ANA InterContinental Tokyo" src="http://www.jcnnewswire.com/image/toppage/ANA_InterContinental_S.jpg"><br /><a href="/pressrelease/95903/3/ANA-InterContinental-Tokyo-unveils-Icon-Reborn-transformation" class="newslink">ANA InterContinental Tokyo unveils Icon Reborn transformation</a><br /><span class="note"> Feb 13, 2025 15:00 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Mitsubishi Heavy Industries, Ltd." src="http://www.jcnnewswire.com/image/toppage/MHI_newT.jpg"><br /><a href="/pressrelease/96010/3/MHI-Thermal-Systems-Receives-Top-Honors-on-Australias-Foremost-Consumer-Review-Platform-for-Two-Seri" class="newslink">MHI Thermal Systems Receives Top Honors on Australia's Foremost Consumer Review Platform for Two Series of Split System Air-Conditioners</a><br /><span class="note"> Feb 13, 2025 12:47 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Honda Motor Co, Ltd" src="http://www.jcnnewswire.com/image/toppage/honda.gif"><br /><a href="/pressrelease/96008/3/Honda-Presents-World-Premiere-of-Seven-Refreshed-Large-size-Outboard-Motors-at-the-Miami-Internation" class="newslink">Honda Presents World Premiere of Seven Refreshed Large-size Outboard Motors at the Miami International Boat Show 2025</a><br /><span class="note"> Feb 13, 2025 10:50 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Fujitsu Ltd" src="http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg"><br /><a href="/pressrelease/96007/3/Fujitsu-to-offer-Fujitsu-Cloud-Service-Generative-AI-Platform-for-secure-and-flexible-enterprise-dat" class="newslink">Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management</a><br /><span class="note"> Feb 13, 2025 10:01 JST</span><br /></td></tr><tr><td class="articleDate"><img title="ULVAC, Inc." src="http://www.jcnnewswire.com/image/toppage/Ulvac.64.jpg"><br /><a href="/pressrelease/95891/3/ULVAC-Develops-Roll-to-Roll-Lithium-Deposition-System,-Unveiling-at-Battery-Japan" class="newslink">ULVAC Develops Roll-to-Roll Lithium Deposition System, Unveiling at Battery Japan</a><br /><span class="note"> Feb 13, 2025 08:30 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Mitsubishi Power" src="http://www.jcnnewswire.com/image/toppage/mitsubishipower.68.jpg"><br /><a href="/pressrelease/95973/3/Mitsubishi-Power-Secures-Major-Gas-Turbine-and-Services-Order-for-Al-Wahda-Open-Cycle-Gas-Turbine-Po" class="newslink">Mitsubishi Power Secures Major Gas Turbine and Services Order for Al Wahda Open Cycle Gas Turbine Power Plant in Morocco</a><br /><span class="note"> Feb 12, 2025 16:21 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Mitsubishi Heavy Industries, Ltd." src="http://www.jcnnewswire.com/image/toppage/MHI_newT.jpg"><br /><a href="/pressrelease/95964/3/MHI-Delivers-Final-7000-Series-AGT-Trainset-for-the-Astram-Line" class="newslink">MHI Delivers Final 7000-Series AGT Trainset for the Astram Line</a><br /><span class="note"> Feb 12, 2025 12:24 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Fujitsu Ltd" src="http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg"><br /><a href="/pressrelease/95960/3/Fujitsu-and-Yokohama-National-University-achieve-worlds-first-real-time-prediction-of-tornadoes-asso" class="newslink">Fujitsu and Yokohama National University achieve world's first real-time prediction of tornadoes associated with typhoons using supercomputer Fugaku</a><br /><span class="note"> Feb 12, 2025 11:37 JST</span><br /></td></tr><tr><td class="articleDate"><img title="NEC Corporation" src="http://www.jcnnewswire.com/image/toppage/NEC.62.jpg"><br /><a href="/pressrelease/95896/3/NEC-Solution-Modernizes-Network-Infrastructure-Construction-Work" class="newslink">NEC Solution Modernizes Network Infrastructure Construction Work</a><br /><span class="note"> Feb 10, 2025 15:05 JST</span><br /></td></tr><tr><td class="articleDate"><img title="Olympus" src="http://www.jcnnewswire.com/image/toppage/Olympus65.jpg"><br /><a href="/pressrelease/95890/3/Olympus-Recognized-on-CDPs-A-List,-the-Highest-Rating-in-the-Field-of-Climate-Change" class="newslink">Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change</a><br /><span class="note"> Feb 10, 2025 11:00 JST</span><br /></td></tr><tr><td class="articleDate"><img title="uSMART" src="http://www.jcnnewswire.com/image/toppage/uSMART68.jpg"><br /><a href="/pressrelease/95851/3/uSMART-Capital,-LLC-officially-approved-for-US-FINRA-license" class="newslink">uSMART Capital, LLC officially approved for U.S. FINRA license</a><br /><span class="note"> Feb 07, 2025 17:40 JST</span><br /></td></tr><tr><td class="articleDate"><img title="TANAKA PRECIOUS METAL GROUP Co., Ltd." src="http://www.jcnnewswire.com/image/toppage/Tanaka_New_Logo_s1.jpg"><br /><a href="/pressrelease/95788/3/TANAKA-to-Provide-Medals-for-the-Tokyo-Marathon-2025-That-Represent-All-the-Participants-in-the-Even" class="newslink">TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines</a><br /><span class="note"> Feb 07, 2025 04:00 JST</span><br /></td></tr></table></span> <a id="MainContent_LatestRelease_MoreRelease" href="/MoreNews_j/3">More Latest Release >></a> </div> <div class="col-lg-3"> <span id="MainContent_RelatedNews_RelatedNews"><div class="sidebar-module-inset"><h4>Related Release</h4><table width="100%" cellpadding=0 cellspacing=0><tr><td><a href="/pressrelease/96056/3/Development-of-Prediction-Model-for-Brain-Amyloid-Beta-Accumulation-for-Early-Screening-of-Alzheimer">Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer&apos;s Disease</a></td></tr><tr><td class="note">2/14/2025 12:09:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/95722/3/Eisai-to-Provide-Guidance-on-Reducing-the-Risk-of-Cognitive-Decline-and-Nutrition,-and-Development-G">Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies</a></td></tr><tr><td class="note">2/3/2025 5:23:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/95573/3/FDA-Approves-LEQEMBI-(lecanemab-irmb)-IV-Maintenance-Dosing-for-the-Treatment-of-Early-Alzheimer&apo">FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer&apos;s Disease</a></td></tr><tr><td class="note">1/28/2025 9:46:00 AM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/95425/3/Eisai-Listed-as-a-Global-100-Most-Sustainable-Corporation-for-The-Ninth-Time-Highest-Ranked-Global-P">Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company</a></td></tr><tr><td class="note">1/22/2025 5:18:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/95256/3/FDA-Accepts-LEQEMBI-(lecanemab-irmb)-Biologics-License-Application-for-Subcutaneous-Maintenance-Dosi">FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer&apos;s Disease</a></td></tr><tr><td class="note">1/15/2025 10:03:00 AM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/95040/3/Elucidation-of-part-of-the-Mechanism-by-which-Lecanemab-Slows-the-Progression-of-Alzheimer&aposs-Dis">Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer&apos;s Disease</a></td></tr><tr><td class="note">1/7/2025 9:14:00 AM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/94804/3/Fujirebio-and-Eisai-Enter-into-Memorandum-of-Understanding-for-Joint-Research-and-Social-Implementat">Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases</a></td></tr><tr><td class="note">12/23/2024 5:22:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/94481/3/Eisai&aposs-&quotURECE(R)&quot-(Dotinurad)-Approved-in-China-for-Gout-Patients-with-Hyperuricemia">Eisai&apos;s &quot;URECE(R)&quot; (Dotinurad) Approved in China for Gout Patients with Hyperuricemia</a></td></tr><tr><td class="note">12/11/2024 2:45:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/94344/3/&quotLEQEMBI&quot-(Lecanemab)-Approved-for-the-Treatment-of-Early-Alzheimer&aposs-Disease-in-Mexico">&quot;LEQEMBI&quot; (Lecanemab) Approved for the Treatment of Early Alzheimer&apos;s Disease in Mexico</a></td></tr><tr><td class="note">12/5/2024 11:22:00 AM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td><a href="/pressrelease/94158/3/LEQEMBI-(Lecanemab)-for-the-Treatment-of-Alzheimer&aposs-Disease-Launched-in-South-Korea">LEQEMBI (Lecanemab) for the Treatment of Alzheimer&apos;s Disease Launched in South Korea</a></td></tr><tr><td class="note">11/28/2024 4:26:00 PM JST</td></tr><tr><td>&nbsp;</td></tr><tr><td align="center"><a href="/CompanyNews/93908/3">More Press release >></a></td></tr></table></dl></div></span> </div> </td></tr> </table> <script type="text/javascript"> $(document).ready(function () { $("#single_1").fancybox({ helpers: { title: { type: 'float' } } }); }); </script> </section> </div> <footer> <div class="content-wrapper"> <div align="center"> Copyright &copy; 2025 - JCN Newswire <div class="botton-nav"> <ul> <li><a href="../../../">Home</a></li> <li><a href="../../../About/">About</a></li> <li><a href="../../../Contact/">Contact</a></li> <li><a href="../../../RssFeed/">RSS</a></li> <li><a href="../../../Cookies/">Cookies Policy</a></li> <li><a href="../../../Disclaimer/">Disclaimer</a></li> <li><a href="../../../Privacy/">Privacy Policy</a></li> <li><a href="../../../Terms/">Terms of Use</a></li> <li>&nbsp;-&nbsp;</li> <li> Connect with us:</li> <li class="nolink"> <a href="https://www.facebook.com/jcnnewswire" target="_blank" class="social"> <i class="fa fa-facebook-square"></i></a> </li> <li class="nolink"> <a href="https://twitter.com/JCNNewswire" target="_blank" class="social"><i class="fa fa-twitter-square"></i></a> </li> <li class="nolink"> <a href="/rssfeed.aspx" class="social"><i class="fa fa-rss-square"></i></a> </li> </ul> </div> </div> </div> </footer> <script type="text/javascript"> //<![CDATA[ var Page_Validators = new Array(document.getElementById("RequiredFieldSearch")); //]]> </script> <script type="text/javascript"> //<![CDATA[ var RequiredFieldSearch = document.all ? document.all["RequiredFieldSearch"] : document.getElementById("RequiredFieldSearch"); RequiredFieldSearch.controltovalidate = "searchstring"; RequiredFieldSearch.errormessage = "*"; RequiredFieldSearch.evaluationfunction = "RequiredFieldValidatorEvaluateIsValid"; RequiredFieldSearch.initialvalue = ""; //]]> </script> <script type="text/javascript"> //<![CDATA[ var Page_ValidationActive = false; if (typeof(ValidatorOnLoad) == "function") { ValidatorOnLoad(); } function ValidatorOnSubmit() { if (Page_ValidationActive) { return ValidatorCommonOnSubmit(); } else { return true; } } //]]> </script> </form> <script> (function (i, s, o, g, r, a, m) i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () (i[r].q = i[r].q || []).push(arguments) }, i[r].l = 1 * new Date(); a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g; m.parentNode.insertBefore(a, m) })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga'); ga('create', 'UA-61831624-1', 'auto'); ga('send', 'pageview'); </script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10